Value Investment Analysis of U.S. Biotech & Pharmaceutical Companies to 2024 - Based on Financial Indicators and Valuation Analysis and Application
DOI:
https://doi.org/10.54097/6046y863Keywords:
Biotechnology, value investing, new crown epidemic, financial metrics, valuation modeling.Abstract
This paper analyzes the value investment in the Biotechnology & Pharmaceuticals industry in 2024 to analyze the investment value and investment risk of American biopharmaceutical companies. In 2024, the first year after the end of the COVID-19, the global economy begins to recover and the biopharmaceutical industry's propensity to evolve changes with the end of the epidemic. The COVID-19 has led to closer ties and cooperation in the global biopharmaceutical industry. Under the new market landscape and competitive dynamics, investments in the biopharmaceutical industry will also change. The high-investment and high-yield characteristics of the biopharmaceutical industry have also made it attracted much attention from investors. At the same time, its high investment risk makes investment analysis and risk assessment particularly important. This paper systematically analyzes the financial operations and value investment opportunities of four biopharmaceutical industries based on financial indicators and valuation models, providing investors with comprehensive industry insights and investment recommendations.
Downloads
References
Ruiqing Zhang. Center for a New American Security releases report "Reinvigorated: Biotechnology and U.S. Industrial Policy". Science and Technology China, 2022, (09): 104.
Piotroski, J. D. Value investing: The use of historical financial statement information to separate winners from losers. Journal of Accounting Research, 2000: 1 - 41.
Kenourgios, D., Papathanasiou, S., & Bampili, A. C. On the predictive power of CAPE or Shiller’s PE ratio: The case of the Greek stock market. Operational Research, 2022: 1 - 20.
Wang Yijin. Based on Peter Lynch's investment philosophy: A study of stock picking strategy with superimposed timing. Investment and Entrepreneurship, 2021.
Liu, J. W., Cheng, C. H., Chen, Y. H., & Chen, T. L. OWA rough set model for forecasting the revenues growth rate of the electronic industry. Expert Systems with Applications, 2010, 37 (1): 610 - 617.
Mahdi, M., & Khaddafi, M. The influence of gross profit margin, operating profit margin and net profit margin on the stock price of consumer good industry in the Indonesia stock exchange on 2012-2014. International Journal of Business, Economics, and Social Development, 2020, 1 (3): 153 - 163.
Kumar, P. Impact of earning per share and price earnings ratio on market price of share: a study on auto sector in India. International Journal of Research, 2017, 5 (2): 113 - 118.
Lajevardi, S. A study on the effect of P/E and PEG ratios on stock returns: Evidence from Tehran Stock Exchange. Management Science Letters, 2014, 4 (7): 1401 - 1410.
Farrell Jr, J. L. The dividend discount model: A primer. Financial Analysts Journal, 1985, 41 (6): 16 - 25.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
